PF 1022AAnthelmintically active cyclodepsipeptide CAS# 133413-70-4 |
- Methylcobalamin
Catalog No.:BCC5188
CAS No.:13422-55-4
- Miglustat hydrochloride
Catalog No.:BCC5186
CAS No.:210110-90-0
- Tirapazamine
Catalog No.:BCC5184
CAS No.:27314-97-2
- Amifampridine
Catalog No.:BCC5185
CAS No.:54-96-6
- Miglustat
Catalog No.:BCC5187
CAS No.:72599-27-0
- Grape Seed Extract
Catalog No.:BCC5317
CAS No.:84929-27-1
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 133413-70-4 | SDF | Download SDF |
| PubChem ID | 159590 | Appearance | Powder |
| Formula | C52H76N4O12 | M.Wt | 949.18 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | DMSO : ≥ 43 mg/mL (45.30 mM) *"≥" means soluble, but saturation unknown. | ||
| Chemical Name | (3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-4,10,12,16,22,24-hexamethyl-3,9,15,21-tetrakis(2-methylpropyl)-1,7,13,19-tetraoxa-4,10,16,22-tetrazacyclotetracosane-2,5,8,11,14,17,20,23-octone | ||
| SMILES | CC1C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)O1)CC(C)C)C)CC2=CC=CC=C2)CC(C)C)C)C)CC(C)C)C)CC3=CC=CC=C3)CC(C)C)C | ||
| Standard InChIKey | YJNUXGPXJFAUQJ-LYWANRAQSA-N | ||
| Standard InChI | InChI=1S/C52H76N4O12/c1-31(2)25-39-49(61)65-35(9)45(57)53(11)42(28-34(7)8)52(64)68-44(30-38-23-19-16-20-24-38)48(60)56(14)40(26-32(3)4)50(62)66-36(10)46(58)54(12)41(27-33(5)6)51(63)67-43(47(59)55(39)13)29-37-21-17-15-18-22-37/h15-24,31-36,39-44H,25-30H2,1-14H3/t35-,36-,39+,40+,41+,42+,43-,44-/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
PF 1022A Dilution Calculator
PF 1022A Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.0535 mL | 5.2677 mL | 10.5354 mL | 21.0708 mL | 26.3385 mL |
| 5 mM | 0.2107 mL | 1.0535 mL | 2.1071 mL | 4.2142 mL | 5.2677 mL |
| 10 mM | 0.1054 mL | 0.5268 mL | 1.0535 mL | 2.1071 mL | 2.6339 mL |
| 50 mM | 0.0211 mL | 0.1054 mL | 0.2107 mL | 0.4214 mL | 0.5268 mL |
| 100 mM | 0.0105 mL | 0.0527 mL | 0.1054 mL | 0.2107 mL | 0.2634 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
PF1022A is a novel anthelmintic cyclodepsipeptide. It was isolated from cultured mycelia of PF1022 Mycelia Sterilia, and exhibited strong anthelmintic activities against Ascaridia galli in chickens. [2] PF1022A seems to be a safe alternative to other anthelmintic drugs [1].
PF1022 is consisted of four alternating residues of N-methyl-L-leucine and four residues of D-phenyl-lactate or D-lactate [3]. PF1022A binds to the latrophilin-like transmembrane receptor and is important for pharyngeal pumping in nematodes. Furthermore, PF1022A binds to GABA receptors, which might contribute to the anthelmintic effect. PF1022A acts as an ionophore. In necrotic cells, PF1022A did not induce cell death indicated by lack of cellular lactate dehydrogenase release. PF1022A-induced cytotoxicity is impacted on the cell cycle and apoptosis regulating proteins p53, bax and p21, but not Bcl-2.
The efficacy of PF 1022A was investigated against the following parasite species: Strongyloides ratti and Nippostrongylus brasiliensis in rats, Ancylostoma caninum in dogs, Trichostrongylus colubriformis and Haemonchus contortus in sheep, small strongyles (cyathostomes) in horses, and Dictyocaulus viviparus in cattle. Oral, subcutaneous or intravenous application at doses varied from 1 to 10 mg/kg body weight was compared in livestock animals. High degrees of efficacy were found in all the above-cited examinations, and no clinical signs of impatience were observed. [4]
References:
Dornetshuber R, Kamyar MR, Rawnduzi P et al. Effects of the anthelmintic drug PF1022A on mammalian tissue and cells. Biochem Pharmacol. 2009 Apr 15;77(8):1437-44.
Sasaki T, Takagi M, Yaguchi T et al. A new anthelmintic cyclodepsipeptide, PF1022A. J Antibiot (Tokyo). 1992 May;45(5):692-7.
Yanai K, Sumida N, Okakura K et al. Para-position derivatives of fungal anthelmintic cyclodepsipeptides engineered with Streptomyces venezuelae antibiotic biosynthetic genes. Nat Biotechnol. 2004 Jul;22(7):848-55. Epub 2004 Jun 6.
Von Samson-Himmelstjerna G, Harder A, Schnieder T. In vivo activities of the new anthelmintic depsipeptide PF 1022A. Parasitol Res. 2000 Mar;86(3):194-9.
- MG-115
Catalog No.:BCC1237
CAS No.:133407-86-0
- MG-132
Catalog No.:BCC1227
CAS No.:133407-82-6
- (+)-Aflavazole
Catalog No.:BCN7339
CAS No.:133401-09-9
- 3-MPPI
Catalog No.:BCC6705
CAS No.:133399-65-2
- Brandioside
Catalog No.:BCN6770
CAS No.:133393-81-4
- Fmoc-β-Homo-D-Tyr(tBu)-OH
Catalog No.:BCC2620
CAS No.:133373-24-7
- 4-Hydroxy-11,12,13-trinor-5-eudesmen-7-one
Catalog No.:BCN6627
CAS No.:133369-42-3
- Fmoc-His(MMt)-OH
Catalog No.:BCC3503
CAS No.:133367-33-6
- DV 7028 hydrochloride
Catalog No.:BCC6202
CAS No.:133364-62-2
- Daturataturin A
Catalog No.:BCN6179
CAS No.:133360-51-7
- Lydicamycin
Catalog No.:BCN1843
CAS No.:133352-27-9
- Lactacystin
Catalog No.:BCN1841
CAS No.:133343-34-7
- 3'-Geranyl-3-prenyl-2',4',5,7-tetrahydroxyflavone
Catalog No.:BCN1583
CAS No.:1334309-44-2
- Angophorol
Catalog No.:BCN3965
CAS No.:133442-54-3
- Heudelotinone
Catalog No.:BCN6180
CAS No.:133453-58-4
- Iloperidone
Catalog No.:BCC2516
CAS No.:133454-47-4
- Fmoc-Glu(OAll)-OH
Catalog No.:BCC3492
CAS No.:133464-46-7
- TAI-1
Catalog No.:BCC5576
CAS No.:1334921-03-7
- SR 1001
Catalog No.:BCC6309
CAS No.:1335106-03-0
- Exendin-3 (9-39) amide
Catalog No.:BCC7257
CAS No.:133514-43-9
- Apigenin 4'-O-rhamnoside
Catalog No.:BCN6181
CAS No.:133538-77-9
- AG-490
Catalog No.:BCC2193
CAS No.:133550-30-8
- Tyrphostin B44, (-) enantiomer
Catalog No.:BCC6703
CAS No.:133550-32-0
- AG 555
Catalog No.:BCC6721
CAS No.:133550-34-2
In vivo activities of the new anthelmintic depsipeptide PF 1022A.[Pubmed:10726989]
Parasitol Res. 2000 Mar;86(3):194-9.
PF 1022A is a member of a new class of cyclic depsipeptides with antiparasitic activity. Following in vitro and laboratory animal studies it was tested for its anthelmintic efficacy in companion and livestock animals against a wide spectrum of intestinal nematodes and lungworms. Studies were carried out in rats, dogs, horses, sheep, and cattle. Animals were either naturally or experimentally infested. The efficacy of PF 1022A was investigated against the following parasite species: Strongyloides ratti and Nippostrongylus brasiliensis in rats, Ancylostoma caninum in dogs, small strongyles (cyathostomes) in horses, Trichostrongylus colubriformis and Haemonchus contortus in sheep, and Dictyocaulus viviparus in cattle. Doses varied from 1 to 10 mg/kg body weight for oral, subcutaneous or intravenous application in companion and livestock animals. High degrees of efficacy were found in all the above-cited examinations, and no clinical signs of intolerability were observed.
